165 related articles for article (PubMed ID: 28529610)
1. Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met.
Chen GZ; Dai WS; Zhu HC; Song HM; Yang X; Wang YD; Min H; Lu Q; Liu S; Sun XC; Zeng XN
J Cancer; 2017; 8(6):983-992. PubMed ID: 28529610
[TBL] [Abstract][Full Text] [Related]
2. HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.
Goltsov AA; Fang B; Pandita TK; Maru DM; Swisher SG; Hofstetter WL
Ann Thorac Surg; 2018 Feb; 105(2):363-370. PubMed ID: 29223420
[TBL] [Abstract][Full Text] [Related]
3. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
[TBL] [Abstract][Full Text] [Related]
4. Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p-EGFR and p-ERK.
Zhao G; Feng L; Ye T; Liu Y; Fan L; Ye C; Chen J
Thorac Cancer; 2023 Aug; 14(22):2127-2138. PubMed ID: 37337933
[TBL] [Abstract][Full Text] [Related]
5. Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma.
Hassan MS; Williams F; Awasthi N; Schwarz MA; Schwarz RE; Li J; von Holzen U
Sci Rep; 2019 Nov; 9(1):17608. PubMed ID: 31772236
[TBL] [Abstract][Full Text] [Related]
6. [Effects and its mechanism of Nimotuzumab on radiosensitivity of esophageal carcinoma ECA-109 and TE-13 cell lines].
Wang J; Wang W; Guo Y; Jing SW; Shang K; Miao MC; Wang J; Wu YJ; Liu LN; Yu JM
Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):732-738. PubMed ID: 27784455
[No Abstract] [Full Text] [Related]
7. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
[TBL] [Abstract][Full Text] [Related]
8. Foretinib (GSK1363089) induces p53-dependent apoptosis in endometrial cancer.
Kogata Y; Tanaka T; Ono YJ; Hayashi M; Terai Y; Ohmichi M
Oncotarget; 2018 Apr; 9(32):22769-22784. PubMed ID: 29854314
[TBL] [Abstract][Full Text] [Related]
9. Artesunate enhances radiosensitivity of esophageal cancer cells by inhibiting the repair of DNA damage.
Fei Z; Gu W; Xie R; Su H; Jiang Y
J Pharmacol Sci; 2018 Oct; 138(2):131-137. PubMed ID: 30337244
[TBL] [Abstract][Full Text] [Related]
10. Liriodenine enhances radiosensitivity in esophageal cancer ECA-109 cells by inducing apoptosis and G
Wu G; Chen G; Zhou J; Zhu H; Chu J; Zhang F
Oncol Lett; 2018 Oct; 16(4):5020-5026. PubMed ID: 30250568
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
12. Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.
Kataoka Y; Mukohara T; Tomioka H; Funakoshi Y; Kiyota N; Fujiwara Y; Yashiro M; Hirakawa K; Hirai M; Minami H
Invest New Drugs; 2012 Aug; 30(4):1352-60. PubMed ID: 21655918
[TBL] [Abstract][Full Text] [Related]
13. Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma.
Huynh H; Ong R; Soo KC
Angiogenesis; 2012 Mar; 15(1):59-70. PubMed ID: 22187171
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt/GSK-3β/Snail Signaling Pathway in Human Esophageal Cancer Cells.
Yang XX; Ma M; Sang MX; Zhang XY; Zou NY; Zhu SC
Onco Targets Ther; 2020; 13():4665-4678. PubMed ID: 32547096
[TBL] [Abstract][Full Text] [Related]
15. Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.
Zillhardt M; Park SM; Romero IL; Sawada K; Montag A; Krausz T; Yamada SD; Peter ME; Lengyel E
Clin Cancer Res; 2011 Jun; 17(12):4042-51. PubMed ID: 21551255
[TBL] [Abstract][Full Text] [Related]
16. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations.
Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R
Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Lüttich L; Besso MJ; Heiden S; Koi L; Baumann M; Krause M; Dubrovska A; Linge A; Kurth I; Peitzsch C
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919702
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
[TBL] [Abstract][Full Text] [Related]
19. Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling.
Sohn SH; Kim B; Sul HJ; Choi BY; Kim HS; Zang DY
Onco Targets Ther; 2020; 13():1027-1035. PubMed ID: 32099405
[TBL] [Abstract][Full Text] [Related]
20. Astaxanthin increases radiosensitivity in esophageal squamous cell carcinoma through inducing apoptosis and G2/M arrest.
Qian X; Tan C; Yang B; Wang F; Ge Y; Guan Z; Cai J
Dis Esophagus; 2017 Jun; 30(6):1-7. PubMed ID: 28475750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
